Riskpilot← Back to searchSign inGet full accessDYREKLINIKKEN SON AS
ASActiveOrg 929365496Slettaveien 2, 1553 SonVeterinary activities · NACE 7500Est. 20228 employeeswww.dyreklinikkenson.no
Revenue 2024
NOK 0
EBITDA margin
—
-59% vs 2023
Equity ratio
68.0%
Financial strength
Net profit 2024
NOK 2M
+17249% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -18K | -59% |
| Net profit | NOK 2M | +17249% |
| Total assets | NOK 10K | -55% |
| Equity | NOK 7K | +189% |
| Employees | 8 | — |
Legal name
DYREKLINIKKEN SON AS
Org number
929365496
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
16. juni 2022
Share capital
NOK 30 000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Drive dyreklinikk, samt annen virksomhet som naturlig hører sammen med dette.
Address
Slettaveien 2, 1553 Son
Website
www.dyreklinikkenson.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 |
| EBITDA | −21 | −11 | −18 |
| Depreciation & amort. | −0 | −0 | −0 |
| EBIT | −21 | −11 | −18 |
| Net financials | 0 | 0 | 1 983 |
| Profit before tax | −21 | −11 | 1 964 |
| Tax | −0 | −0 | −0 |
| Net profit | −21 | −11 | 1 964 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 36 | 22 | 10 |
| Equity | 4 | −8 | 7 |
| Long-term debt | 30 | 30 | 0 |
| Short-term debt | 2 | 0 | 3 |
| Total debt | 32 | 30 | 3 |
EBITDA margin
-1815800.0%
This company
15.8%
Market median
-11492505% vs market
20222024
Equity ratio
68.0%
This company
38.2%
Market median
+78% vs market
20222024
Return on equity
28766.5%
This company
18.4%
Market median
+156240% vs market
20222024
Net profit margin
196446700.0%
This company
8.1%
Market median
+2425267801% vs market
20222024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222024
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MC Chief Executive Officer | Chief Executive Officer | 2025 |
MD Chief Executive Officer | Chief Executive Officer | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Board of Directors | 2026 | |
| Board of Directors | 2026 | |
| Board of Directors | 2022 | |
| Board of Directors | 2026 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 66% | 66% | 2023 | |
| Company | 34% | 34% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tronaas Utvikling As
DYREKLINIKKEN SON AS Board members of DYREKLINIKKEN SON AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mai-Gret Cathrin Jacobsen | Chief Executive Officer | 0 companies |
| Martine De Courcy Boxill | Chief Executive Officer | 0 companies |
| Karl Patrik Mandelin | Board of Directors | 0 companies |
| Marianne Jensen Mandelin | Board of Directors | 0 companies |
| Atle Henrik Andresen | Board of Directors | 0 companies |
| Allan Ludvigsen | Board of Directors | 0 companies |
| Terje Baardseth | Chairman | 0 companies |
| Lars Gunnar Karlsøen Tronaas | Board of Directors | 0 companies |